ASPIC

send to a friend share this

Prémio Pulido Valente Ciência 2014 para investigação sobre telomerase

O investigador João Vinagre foi distinguido com o Prémio Pulido Valente Ciência 2014, por ter identificado que o aumento de uma proteína, a telomerase, é comum em cancros mais agressivos da tiróide, bexiga e do sistema nervoso central.

 

Peroxisomes are involved in malignant transformation in prostate cancer

Monocarboxylate transporter 2 (MCT2) is overexpressed in prostate malignant glands, pointing it out as a putative biomarker for prostate cancer. In this study, it was demonstrated that MCT2 localizes mainly at peroxisomes in prostate cancer cells and is able to take advantage of the peroxisomal transport machinery. It was also shown an increase in MCT2 expression from non-malignant to malignant cells that was directly correlated with its peroxisomal localization.

Os peroxissomas estão envolvidos na transformação maligna no cancro da próstata

O transportador de monocarboxilatos 2 (MCT2) está sobre-expresso na glândula da próstata maligna, sendo apontado como um biomarcador putativo no cancro da próstata. Neste estudo, foi demonstrado que o MCT2 se localiza principalmente nos peroxissomas das células de cancro da próstata, tirando partido da maquinaria de transporte peroxisomal.

Strike a balance between advanced breast cancer eradication and E-cadherin restoration: EMT events in the spotlight

Cancer cells often express a massive amount of proteins that are needed to their own proliferation.  One of the molecular abnormalities related to tumour progression, invasion and fixation requires the impairment of E-cadh expression, a tumour invasion suppressor protein. Epithelial‑mesenchymal transitions (EMT), is associated with the silencing of E-cad expression and further expression of EMT related molecules, such as Akt2 and Twist, crucial for progression of non-invasive into a malignant metastatic carcinomas, due to a polarity and adhesion loss between adjacent cells.

Explorar a dependência entre a reposição dos níveis de E-caderina e a erradicação do cancro da mama avançado: modulação dos mecanismos de EMT

A terapêutica convencional em oncologia, a cirurgia, a quimioterapia e/ou radioterapia, apresentam falta de selectividade para a célula neoplásica. Recentemente quer a imunoterapia quer a terapia génica trouxeram enormes expectativas. No que respeita à célula neoplásica, os factores de crescimento, a angiogénese, a metastização e regulação do ciclo celular podem ser alvos preferenciais na terapêutica oncológica. O papel dos factores de transcrição celular em mecanismos subjacentes à aquisição do potencial metastático tem sido estudado.

Call for papers: The Cellular Redox System in Cancer, Cardiovascular and Neurodegenerative diseases

The journal «Oxidative Medicine and Cellular Longevity» is inviting renowned researchers to contribute to original research articles as well as review articles that will promote the understanding of the role of the cellular redox regulatory system in human diseases:

Call for papers: The Cellular Redox System in Cancer, Cardiovascular and Neurodegenerative diseases

The journal «Oxidative Medicine and Cellular Longevity» is inviting renowned researchers to contribute to original research articles as well as review articles that will promote the understanding of the role of the cellular redox regulatory system in human diseases:

XXIII Porto Cancer Meeting - Stem Cells and Cancer

Ipatimup - Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal

 

7 - 8 May, 2015

 

See more informations here: https://www.ipatimup.pt/Site/Activityview.aspx?ActivityId=2655

XXIII Porto Cancer Meeting - Stem Cells and Cancer

Ipatimup - Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal

 

7 - 8 May, 2015

 

See more informations here: https://www.ipatimup.pt/Site/Activityview.aspx?ActivityId=2655

10th AORTIC International Cancer Conference

Palais des Congrès de Marrakech, Marrakech, Morocco

 

18 - 22 November, 2015

 

See more informations here: http://aorticconference.org/